Prognostic Risk Classification for Biochemical Relapse-Free Survival in Patients With Oligorecurrent Prostate Cancer After [68Ga]PSMA-Pet-Guided Metastasis-Directed Therapy

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-020-04760-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

68Ga PSMA-11 PET With CT Urography Protocol in the Initial Staging and Biochemical Relapse of Prostate Cancer

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2017English

Impact of Germline CHEK2 Mutations on Biochemical Relapse Free Survival and Metastasis Free Survival After Radical Treatment for Patients With Prostate Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Scientific Reports
Multidisciplinary
2020English

Comparison of [18F]DCFPyL and [68Ga]Ga-Psma-Hbed-Cc for PSMA-PET Imaging in Patients With Relapsed Prostate Cancer

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

68Ga-Psma Ligand PET/CT in Patients With Prostate Cancer: How We Review and Report

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2016English

(OA35) Impact of Staging 68Ga-Psma-11 Pet Scans on Radiation Treatment Plans in Patients With Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Diagnostic Performance of 18f-Psma-1007 PET/CT in Patients With Biochemical Recurrent Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2018English

Diagnostic Performance of 68Ga-Psma-11 (HBED-CC) PET/CT in Patients With Recurrent Prostate Cancer: Evaluation in 1007 Patients

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy